Bridgebio Oncology Therapeutics, Inc. (BBOT)

8.87 +0.07 (+0.80%) USD  |  NASDAQ  |  Apr 29, 09:38
More

Bridgebio Oncology Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for BBOT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
EyePoint, Inc. Upgrade
Praxis Precision Medicines, Inc. Upgrade
Rapport Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade